155 related articles for article (PubMed ID: 32481349)
1. The expression of epidermal growth factor receptor 1 and human epidermal growth factor receptor 2 based on tumor location affect survival in gastric cancer.
Li GC; Jia XC; Zhao QC; Zhang HW; Yang P; Xu LL; Pang FN; Sun JB
Medicine (Baltimore); 2020 May; 99(21):e20460. PubMed ID: 32481349
[TBL] [Abstract][Full Text] [Related]
2. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/body and antrum.
Pinto-De-Sousa J; David L; Seixas M; Pimenta A
Dig Surg; 2001; 18(2):102-10. PubMed ID: 11351154
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological difference between gastric cancer in the lesser curvature and gastric cancer in the greater curvature.
Li GC; Zhang HW; Tian HG; Zhao Y; Huang QX; Xu ZY; Xi XH; Zhang K
Medicine (Baltimore); 2022 Aug; 101(33):e29984. PubMed ID: 35984169
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer.
García I; Vizoso F; Martín A; Sanz L; Abdel-Lah O; Raigoso P; García-Muñiz JL
Ann Surg Oncol; 2003 Apr; 10(3):234-41. PubMed ID: 12679307
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
[TBL] [Abstract][Full Text] [Related]
7. Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival.
Kim JS; Kim MA; Kim TM; Lee SH; Kim DW; Im SA; Kim TY; Kim WH; Yang HK; Heo DS; Bang YJ; Lee KU; Choe KJ; Kim NK
Br J Cancer; 2009 Mar; 100(5):732-8. PubMed ID: 19259093
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cyclooxygenase-2, epidermal growth factor receptor 1, and microvascular density in gastric cancer.
Al-Moundhri MS; Al-Hadabi I; Al-Mawaly K; Kumar S; Al-Lawati FA; Bhatnager G; Kuruvila S; Al-Hamdani A; El-Sayed SM; Al-Bahrani B
Med Oncol; 2012 Sep; 29(3):1739-47. PubMed ID: 22048943
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal growth factor receptor 2-, epidermal growth factor receptor-, and mesenchymal epithelial transition factor-positive sites of gastric cancer using surgical samples.
Oono Y; Kuwata T; Takashima K; Shinmura K; Hori K; Yoda Y; Ikematsu H; Shitara K; Kinoshita T; Yano T
Gastric Cancer; 2019 Mar; 22(2):335-343. PubMed ID: 29951752
[TBL] [Abstract][Full Text] [Related]
12. Relationship between expression of NADPH oxidase 2 and invasion and prognosis of human gastric cancer.
Wang P; Shi Q; Deng WH; Yu J; Zuo T; Mei FC; Wang WX
World J Gastroenterol; 2015 May; 21(20):6271-9. PubMed ID: 26034362
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of clinicopathologic characteristics of gastric cancer patients undergoing gastrectomy based on a single-center gastric cancer database with above 10 000 cases].
Liang WQ; Xi HQ; Qiao S; Cui JX; Zhang KC; Gao YH; Song YN; Zhang L; Luo H; Wei B; Xue WG; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1051-1058. PubMed ID: 33212553
[No Abstract] [Full Text] [Related]
14. Clinical significance of epidermal growth factor receptor content in gastric cancer.
García I; Vizoso F; Andicoechea A; Raigoso P; Vérez P; Alexandre E; García-Muñiz JL; Allende MT
Int J Biol Markers; 2001; 16(3):183-8. PubMed ID: 11605731
[TBL] [Abstract][Full Text] [Related]
15. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
Kurokawa Y; Matsuura N; Kimura Y; Adachi S; Fujita J; Imamura H; Kobayashi K; Yokoyama Y; Shaker MN; Takiguchi S; Mori M; Doki Y
Gastric Cancer; 2015 Oct; 18(4):691-7. PubMed ID: 25224659
[TBL] [Abstract][Full Text] [Related]
16. HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
Makatsoris T; Tsamandas AC; Strimpakos A; Alexopoulou Z; Dionysopoulos D; Pervana S; Konstantara A; Papakostas P; Samantas E; Rallis G; Dimou A; Pentheroudakis G; Papaparaskeva K; Psyrri A; Kalogeras KT; Syrigos K; Scopa CD; Fountzilas G
Anticancer Res; 2016 Apr; 36(4):1581-90. PubMed ID: 27069134
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery.
Galizia G; Lieto E; Orditura M; Castellano P; Mura AL; Imperatore V; Pinto M; Zamboli A; De Vita F; Ferraraccio F
World J Surg; 2007 Jul; 31(7):1458-68. PubMed ID: 17516110
[TBL] [Abstract][Full Text] [Related]
18. Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.
Terashima M; Kitada K; Ochiai A; Ichikawa W; Kurahashi I; Sakuramoto S; Katai H; Sano T; Imamura H; Sasako M;
Clin Cancer Res; 2012 Nov; 18(21):5992-6000. PubMed ID: 22977193
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor and c-erbB-2 contents in unresectable (UICC R1 or R2) gastric cancer.
García I; del Casar JM; Corte MD; Allende MT; García-Muñiz JL; Vizoso F
Int J Biol Markers; 2003; 18(3):200-6. PubMed ID: 14535591
[TBL] [Abstract][Full Text] [Related]
20. [Study on the clinicopathologic characteristics and prognostic difference of gastric stump cancer between non-anastomotic site and anastomotic site].
Chen L; Wei S; Ye Z; Wang Y; Zheng Q; Zhuo C; Xiao J; Zeng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jan; 20(1):67-72. PubMed ID: 28105623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
